Growing community of inventors

Seoul, South Korea

Tae Yeon Lee

Average Co-Inventor Count = 7.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Tae Yeon LeeDong Ki Lee (3 patents)Tae Yeon LeeSun Woo Hong (3 patents)Tae Yeon LeeJi Hyun Kim (2 patents)Tae Yeon LeeYu Ran Na (2 patents)Tae Yeon LeeYoung-Dong Kim (2 patents)Tae Yeon LeeSae-Lo-Oom Lee (2 patents)Tae Yeon LeeHanna Lee (1 patent)Tae Yeon LeeDayeon Yu (1 patent)Tae Yeon LeeJi Eom (1 patent)Tae Yeon LeeSae Lo Oom Lee (1 patent)Tae Yeon LeeTae Yeon Lee (3 patents)Dong Ki LeeDong Ki Lee (16 patents)Sun Woo HongSun Woo Hong (12 patents)Ji Hyun KimJi Hyun Kim (129 patents)Yu Ran NaYu Ran Na (2 patents)Young-Dong KimYoung-Dong Kim (2 patents)Sae-Lo-Oom LeeSae-Lo-Oom Lee (2 patents)Hanna LeeHanna Lee (11 patents)Dayeon YuDayeon Yu (3 patents)Ji EomJi Eom (3 patents)Sae Lo Oom LeeSae Lo Oom Lee (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Olix Pharmaceuticals, Inc. (3 from 15 patents)


3 patents:

1. 10829761 - Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor

2. 10519449 - Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB

3. 10301628 - Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…